核酸抽出における磁性ビーズ原料の市場調査レポート

Market status

The global market size of nucleic acid extraction magnetic beads is expected to reach $2.044 億で 2024. 感染症流行後の需要減退の影響を受けるも, it still maintains a compound annual growth rate of 5.27% driven by technological iteration. The domestic market shows a rapid growth trend, with a compound growth rate of over 25% から 2020 に 2024, and the scale is expected to exceed 20 billion yuan in 2025. With the advantages of high throughput and automation, the penetration rate of magnetic bead method continues to improve in molecular diagnosis, gene sequencing and other fields.

competition pattern

The market competition pattern is dominated by international giants, with Thermo Fisher, Roche, キアゲン, and Beckman occupying the main share. Its magnetic bead raw materials (such as Thermol’s Dynabeads and Beckman’s AMPure XP) are regarded as the “ゴールドスタンダード” in the industry due to their stability and high compatibility.

Domestic enterprises such as Shanghai LingJun Biotech, Suzhou Beaver Biology and Jifan Biology gradually realize import substitution through technological breakthroughs; Na Micro Technology (listed in 2021) has completed the pilot test of chemiluminescent magnetic beads, and Arun Micro nano (a subsidiary of Zhijiang Biology) has mastered the international leading surface modification technology. で 2024, the market share of domestic magnetic bead manufacturers will increase to 35%, an increase of 15 percentage points compared with 2020. Middle and downstream enterprises such as Huada Intelligent Manufacturing and Mindray Medical will also lay out self-developed magnetic beads. で 2022, CR3 (the market share of the top three enterprises) was not disclosed, but the penetration rate of local enterprises in the middle and low-end market was significantly increased.

Material innovation and function expansion:

Magnetic bead surface modification technology: silicon hydroxyl (SiO₂), カルボキシル (-コー) and other functional groups are optimized to improve nucleic acid adsorption efficiency, such as metal organic polymer modified magnetic beads developed by Wu Lidong team, which has been applied in novel coronavirus detection;

High-throughput automation: the demand for magnetic bead raw materials adapted to the 96-channel extraction instrument has surged, promoting enterprises to develop products with better dispersion and faster magnetic response;

Application scenario extension: In addition to traditional pathogen detection, using magnetic beads in NGS library building, 単一細胞シーケンス, and exosome isolation is expanded, such as AMPure XP magnetic beads in second-generation sequencing for fragment screening.

あpplication area

Medical diagnosis: infectious diseases (such as COVID-19, HPV), tumor gene testing and genetic disease screening;

Scientific research and pharmaceutical production: gene editing, nucleic acid purification in drug development;

Forensic and agricultural: sample trace DNA extraction and transgene testing.

将来, as domestic enterprises break through the technical barriers of the whole chain of “magnetic bead-reagent-equipment” and the promotion of precision medical policies, China’s magnetic bead raw material market is expected to achieve a breakthrough in localization in the high-end field, and is expected to form a multi-level competition pattern by 2030. At the supply chain level, the supply of domestic magnetic beads reached 320 million copies in 2024, covering more than 80% of nucleic acid extraction reagent manufacturers.

サプライヤー

上海霊軍生物技術有限公司, 株式会社に設立されました 2016 生体磁性材料と核酸抽出試薬の専門メーカーです.

核酸抽出・精製の経験が豊富です。, タンパク質の精製, 細胞分離, 化学発光, その他の技術分野.

当社の製品はさまざまな分野で広く使用されています, 医療検査など, 遺伝子検査, 大学の研究, 遺伝子育種, 等々. 製品のご提供だけでなくOEMも承ります, ODM, その他のニーズ. 関連するニーズがある場合, お気軽にお問い合わせください .